دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Targeting a Hallmark of Crohn’s Disease: Browning of the Hypertrophic Mesenteric Adipose Tissue as a Novel Strategy to Reduce Inflammation?
Markus Tschurtschenthaler, Bram Verstockt
doi : 10.1093/ecco-jcc/jjad059
Journal of Crohn's and Colitis, Volume 17, Issue 8, August 2023, Pages 1177–1178
Browning of Mesenteric White Adipose Tissue in Crohn’s Disease: A New Pathological Change and Therapeutic Target
Lugen Zuo, Zhijun Geng, Xue Song, Jing Li, Yueyue Wang, Xiaofeng Zhang, Sitang Ge, Lian Wang, Guangyong Liu, Lele Zhang, Mengyu Xu, Yajing Zhao, Li Shen, Yuanyuan Ge, Rong Wu, Jianguo Hu
doi : 10.1093/ecco-jcc/jjad046
Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn’s Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn’s Disease (iCREST-CD)
Takayuki Yamamoto, Hiroshi Nakase, Kenji Watanabe, Shinichiro Shinzaki, Noritaka Takatsu, Toshimitsu Fujii, Ryuichi Okamoto, Katsuyoshi Matsuoka, Akihiro Yamada, Reiko Kunisaki, Minoru Matsuura, Hisashi Shiga, Shigeki Bamba, Yohei Mikami, Takahiro Shimoyama, Satoshi Motoya, Takehiro Torisu, Taku Kobayashi, Naoki Ohmiya, Masayuki Saruta, Koichiro Matsuda, Takayuki Matsumoto, Atsuo Maemoto, Yoko Murata, Shinichi Yoshigoe, Shinya Nagasaka, Tsutomu Yajima, Tadakazu Hisamatsu, iCREST-CD Study Group
doi : 10.1093/ecco-jcc/jjad038
Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial
Iris Dotan, Brian G Feagan, Virginia Taliadouros, Alessandra Oortwijn, Christine Rudolph, Angela de Haas, Eva Santermans, Jeremy Hsieh, Laurent Peyrin-Biroulet, Toshifumi Hibi
doi : 10.1093/ecco-jcc/jjad039
Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies
Fabio Salvatore Macaluso, Marco Ventimiglia, Ambrogio Orlando
doi : 10.1093/ecco-jcc/jjad043
Anal High-risk Human Papillomavirus Infection, Squamous Intraepithelial Lesions, and Anal Cancer in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Andreia Albuquerque, Carmelina Cappello, Oliver Stirrup, Christian P Selinger
doi : 10.1093/ecco-jcc/jjad045
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn’s Disease
Matthieu Allez, Bruce E Sands, Brian G Feagan, Geert D’Haens, Gert De Hertogh, Charles W Randall, Bin Zou, Jewel Johanns, Christopher O’Brien, Mark Curran, Rory Rebuck, Mei-Lun Wang, Nina Sabins, Thomas Baker, Taku Kobayashi
doi : 10.1093/ecco-jcc/jjad047
Anorectal Function and Clinical Characteristics Associated with Faecal Incontinence in Patients with Crohn’s Disease
Lina Maria Góes de Codes, Ana Carolina Costa de Jesus, João Jorge Góes de Codes, Reginaldo Freitas Ferreira, Carolina da Silva Beda Sacramento, Isabela Dias Marques da Cruz, Flávia de Castro Ribeiro Fidelis, Alexandre Lopes de Carvalho, Marina Pamponet Motta, Cândida de Oliveira Alves, Eduardo Martins Netto, Genoile Oliveira Santana
doi : 10.1093/ecco-jcc/jjad048
Serum Immune Profiling in Paediatric Crohn’s Disease Demonstrates Stronger Immune Modulation With First-Line Infliximab Than Conventional Therapy and Pre-Treatment Profiles Predict Clinical Response to Both Treatments
Maria M E Jongsma, Lea M M Costes, Irma Tindemans, Martinus A Cozijnsen, Rolien (H) C Raatgreep, Merel van Pieterson, Yunlei Li, Johanna C Escher, Lissy de Ridder, Janneke N Samsom
doi : 10.1093/ecco-jcc/jjad049
Intestinal Epithelial Cell-specific Deletion of Cytokine-inducible SH2-containing Protein Alleviates Experimental Colitis in Ageing Mice
Xiaoming Hu, Fuxin Jiao, Jiali Deng, Ziheng Zhou, Shanghai Chen, Changqin Liu, Zhanju Liu, Feifan Guo
doi : 10.1093/ecco-jcc/jjad041
Exosomal miR-103a-3p from Crohn’s Creeping Fat-Derived Adipose-Derived Stem Cells Contributes to Intestinal Fibrosis by Targeting TGFBR3 and Activating Fibroblasts
Wenwei Qian, Yihan Xu, Weiwei Wen, Liangyu Huang, Zhen Guo, Weiming Zhu, Yi Li
doi : 10.1093/ecco-jcc/jjad042
Microbial–Immune Crosstalk in Elderly-Onset Inflammatory Bowel Disease: Unchartered Territory
Guanmin Meng, Tanya M Monaghan, Niharika A Duggal, Paddy Tighe, Farhad Peerani
doi : 10.1093/ecco-jcc/jjad025
Recruitment and Residence of Intestinal T Cells – Lessons for Therapy in Inflammatory Bowel Disease
Hannah Gordon, Beverley Rodger, James O Lindsay, Andrew J Stagg
doi : 10.1093/ecco-jcc/jjad027
Artificial Intelligence in Inflammatory Bowel Disease Endoscopy: Implications for Clinical Trials
Harris A Ahmad, James E East, Remo Panaccione, Simon Travis, James B Canavan, Keith Usiskin, Michael F Byrne
doi : 10.1093/ecco-jcc/jjad029
Tofacitinib for Acute Severe Ulcerative Colitis: A Systematic Review
Casper Steenholdt, Pernille Dige Ovesen, Jørn Brynskov, Jakob Benedict Seidelin
doi : 10.1093/ecco-jcc/jjad036
Longitudinal Bile Acid Composition Changes Following Faecal Microbiota Transplantation for Clostridioides difficile Infection in Children With and Without Underlying Inflammatory Bowel Disease
Lea Ann Chen, Maria Oliva-Hemker, Arielle Radin, Melissa Weidner, Brynn D O’Laughlin, Cynthia L Sears, Norman B Javitt, Suchitra K Hourigan
doi : 10.1093/ecco-jcc/jjad057
Erratum to: Intestinal Epithelial Cell-specific Deletion of Cytokine-inducible SH2-containing Protein Alleviates Experimental Colitis in Ageing Mice
doi : 10.1093/ecco-jcc/jjad081
Correction to: Corticosteroid-Sparing Effects of Filgotinib in Moderately to Severely Active Ulcerative Colitis: Data from the Phase 2b/3 SELECTION Study
doi : 10.1093/ecco-jcc/jjad082
